Market Overview
The South Korea pet healthcare market is forecast to grow by USD 34.8 million over the next five years, with annual growth averaging close to 5.79% through 2031. Expansion will be led by pet dietary supplements, as owners become more proactive in managing long-term wellbeing rather than waiting for illness to emerge. Longer pet lifespans, stronger emotional attachment and rising awareness of preventive care are turning supplements into a more routine part of pet ownership, especially among consumers seeking support for ageing, breed-specific risks and lifestyle-related needs.
Personalised health management is becoming a stronger purchase driver. South Korean owners are increasingly looking for products tailored to breed, age, health condition and daily routine, reflecting a more sophisticated understanding of pet nutrition. This creates room for supplements positioned around joints, digestion, immunity, skin and coat care, but it also raises the bar for credibility. In a crowded market where many products can be developed through OEM and ODM channels, brands will need to differentiate through trust, evidence and clearly communicated benefits rather than formula claims alone.
Veterinarians are becoming central to consumer influence. As well-known vets build large audiences through YouTube, media and social platforms, their recommendations are shaping product discovery and purchasing behaviour. Brands and e-commerce platforms are likely to deepen collaborations with veterinary experts to strengthen authority, educate owners and support personalised product recommendations. This professional endorsement will be especially important in healthcare, where consumers are more cautious and more willing to rely on trusted guidance.
Economic uncertainty will moderate premiumisation. While pet owners remain willing to invest in health, spending on non-essential or ultra-premium products is becoming more selective. Mid-range healthcare products that balance efficacy, affordability and professional credibility are likely to gain traction as consumers seek value without abandoning preventive care. The strongest performers will be those that make regular supplementation feel practical, trustworthy and financially reasonable within everyday pet-care routines.
This report delivers a deep dive into the South Korea pet healthcare market, combining historical performance data from 2021 onward with forward-looking projections through 2031. It uncovers critical insights into market size, growth rates, and key trends, providing a clear view of the industry’s evolution. By breaking down the market across product type and distribution channel, the report identifies actionable opportunities for stakeholders to drive growth and outperform competitors.
What’s Inside the Report
Designed for business leaders and strategists, this report offers a data-rich overview of the South Korea pet healthcare market from 2021 to 2031, including historical data and projections through 2031. All figures are reported in (KRW/USD), with compound annual growth rates (CAGR) calculated for both periods. The analysis spans key dimensions such as product type and distribution channel. This structure enables decision-makers to isolate growth-driving segments and align resource allocation with emerging market opportunities.
In addition to market size data, the report also delves into the key factors driving market evolution. Based on industry interviews and authoritative macroeconomic data, the report analyzes the key drivers behind market size fluctuations and outlines future development trends. It integrates insights on innovation, shifts in consumer behavior, and environmental changes to dissect market growth drivers and potential risks. Special focus is placed on high-performing growth areas within sub-markets, as well as opportunities arising from product innovations.
A competitive benchmarking section tracks market share movements and brand positioning among key players from 2021 onward. The report maps consolidation trends, share shifts, and differentiation strategies, equipping stakeholders with actionable insights for portfolio optimization and long-term planning.
Market Segmentation
The South Korea pet healthcare market is categorized into the following segments:
Product type – e.g., flea and tick prevention products, pet vitamins and supplements, pet wormers, others
Distribution channel – e.g., convenience stores, e-commerce, hypermarkets, liquor/tobacco shops, small grocery stores, supermarkets, others
Macroeconomic & Demographic Indicators
Supporting context includes:
Total population
Consumer Price Index (CPI)
Gross Domestic Product (GDP)
Per capita consumption
Consumer spending as a percentage of GDP
These variables enhance understanding of consumption potential and macroeconomic trends affecting the market.
Competitive Landscape: Market Share Analysis
Updated market share data for major industry players in South Korea pet healthcare market is included in the report, providing a snapshot of current competitive alignment. Key players covered include: ALC INovators, Inc., Alchem Bio Co., Ltd., Anbio Inc., Boehringer Ingelheim Auslandsbeteiligungs GmbH, Cho and Kang Co., Ltd., Chong Kun Dang Holdings Corp., Daewoong Pharmaceutical Co., Ltd., Forcans Inc., GREEN VET Co., Ltd., Korea Nutrition Research Center (KNRC), SB Biopharm, Think Pets Co., Ltd., Vetoquinol SA, Virbac S.A., etc.
This section helps stakeholders evaluate market concentration, identify partnership opportunities, and track shifts in leadership.
Why Choose This Report?
Designed as a concise, data-rich market snapshot, this report is ideal for stakeholders seeking timely, reliable, and strategic insights. Whether you’re an investor, operator, consultant, or supplier, the data-driven structure supports confident, evidence-based decision-making.
Request a redacted sample to preview the data structure and presentation quality before purchase.
Deliverables Include
Professionally structured PDF report
Full EXCEL databook with year-by-year figures and multi-dimensional segmentation from 2021 to 2031
Table of Contents
TABLE OF CONTENTS
Market Segmentation
Market Overview
South Korea Pet Healthcare Market – Product Type Analysis
South Korea Pet Healthcare Market – Distribution Channel Analysis
Company/Brand Shares Analysis
ALC INovators, Inc.
Alchem Bio Co., Ltd.
Anbio Inc.
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Cho and Kang Co., Ltd.
…
Macroeconomic Data and Forecast
Research Methodology
Disclaimer
FIGURES AND TABLES
Table South Korea Pet Healthcare Market 2021-2031
Chart South Korea Pet Healthcare Market, Net Growth, 2021-2031
Chart South Korea Pet Healthcare Market, Growth Rates, 2021-2031
Table South Korea Pet Healthcare Market by Product Type, 2021-2031
Chart South Korea Pet Healthcare Market by Product Type, CAGR Historic and Forecast, 2021-2031
Chart South Korea Pet Healthcare Market by Product Type, 2021-2031
Table South Korea Pet Healthcare Market by Distribution Channel, 2021-2031
Chart South Korea Pet Healthcare Market by Distribution Channel, CAGR Historic and Forecast, 2021-2031
Chart South Korea Pet Healthcare Market by Distribution Channel, 2021-2031
Table South Korea Pet Healthcare Market Share (%), by Companies, 2021-2025
Chart South Korea Pet Healthcare Market, by Companies, 2025
Table South Korea Pet Healthcare Market Share (%), by Brands, 2021-2025
Chart South Korea Pet Healthcare Market, by Brands, 2025
Table South Korea – Population (Millions) and Forecast
Table South Korea – Consumer Price Index (CPI) and Forecast
Table South Korea – Gross Domestic Product and Forecast
Table South Korea Pet Healthcare Market: Spend as a Proportion of GDP (%)
Table South Korea Pet Healthcare Market: Consumption per Capita (Population)
Companies Mentioned
This report profiles the following South Korea Pet Healthcare companies:
ALC INovators, Inc.
Alchem Bio Co., Ltd.
Anbio Inc.
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Cho and Kang Co., Ltd.
Chong Kun Dang Holdings Corp.
Daewoong Pharmaceutical Co., Ltd.
Forcans Inc.
GREEN VET Co., Ltd.
Korea Nutrition Research Center (KNRC)
SB Biopharm
Think Pets Co., Ltd.
Vetoquinol SA
Virbac S.A.
